DE3275922D1 - Novel substituted alkanoylimidazol-2-one derivatives - Google Patents

Novel substituted alkanoylimidazol-2-one derivatives

Info

Publication number
DE3275922D1
DE3275922D1 DE8282110157T DE3275922T DE3275922D1 DE 3275922 D1 DE3275922 D1 DE 3275922D1 DE 8282110157 T DE8282110157 T DE 8282110157T DE 3275922 T DE3275922 T DE 3275922T DE 3275922 D1 DE3275922 D1 DE 3275922D1
Authority
DE
Germany
Prior art keywords
alkanoylimidazol
derivatives
novel substituted
hydrogen
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282110157T
Other languages
German (de)
English (en)
Inventor
J Martin Grisar
Richard A Schnettler
Richard C Dage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3275922D1 publication Critical patent/DE3275922D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Fats And Perfumes (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DE8282110157T 1981-11-04 1982-11-04 Novel substituted alkanoylimidazol-2-one derivatives Expired DE3275922D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/317,962 US4367236A (en) 1981-11-04 1981-11-04 Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives

Publications (1)

Publication Number Publication Date
DE3275922D1 true DE3275922D1 (de) 1987-05-07

Family

ID=23236015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282110157T Expired DE3275922D1 (de) 1981-11-04 1982-11-04 Novel substituted alkanoylimidazol-2-one derivatives

Country Status (17)

Country Link
US (1) US4367236A (enExample)
EP (1) EP0079049B1 (enExample)
JP (1) JPS5885867A (enExample)
KR (1) KR890001152B1 (enExample)
AT (1) ATE26264T1 (enExample)
AU (1) AU555244B2 (enExample)
CA (1) CA1227487A (enExample)
DE (1) DE3275922D1 (enExample)
DK (1) DK161251C (enExample)
ES (1) ES8402826A1 (enExample)
GB (1) GB2112383B (enExample)
GR (1) GR77053B (enExample)
IE (1) IE54279B1 (enExample)
NO (1) NO156567C (enExample)
NZ (1) NZ202349A (enExample)
PH (1) PH22079A (enExample)
ZA (1) ZA827973B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
US4868197A (en) * 1987-03-20 1989-09-19 Merrell Dow Pharmaceuticals Inc. Reducing reperfusion injury with 1,3-dihydro-4-methyl-5-(4-methylthio)benzoyl)-2H-imidazol-2-thione
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
WO1994021658A1 (en) * 1993-03-15 1994-09-29 Kalman Thomas I Antiviral imidazolinone nucleoside derivatives
EP1193258A4 (en) * 1999-06-22 2002-11-13 Takeda Chemical Industries Ltd PROCESS FOR THE PREPARATION OF IMIDAZOLE DERIVATIVES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US2441935A (en) * 1946-03-14 1948-05-18 Hoffmann La Roche Imidazolidones and method for their manufacture
US2514380A (en) * 1946-12-26 1950-07-11 Hoffmann La Roche Diamines and method of production
US3303199A (en) * 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
GB1054708A (enExample) * 1964-10-02
JPS5088086A (enExample) * 1973-12-07 1975-07-15
JPS545447A (en) * 1977-06-14 1979-01-16 Fuji Photo Film Co Ltd Recording material
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use

Also Published As

Publication number Publication date
IE54279B1 (en) 1989-08-16
ES517041A0 (es) 1984-03-01
ATE26264T1 (de) 1987-04-15
DK161251B (da) 1991-06-17
NO156567B (no) 1987-07-06
IE822620L (en) 1983-05-04
JPS5885867A (ja) 1983-05-23
EP0079049A3 (en) 1983-06-22
US4367236A (en) 1983-01-04
NZ202349A (en) 1986-04-11
KR840002361A (ko) 1984-06-25
PH22079A (en) 1988-05-20
DK488782A (da) 1983-05-05
KR890001152B1 (ko) 1989-04-25
NO156567C (no) 1987-10-14
DK161251C (da) 1991-12-02
EP0079049B1 (en) 1987-04-01
EP0079049A2 (en) 1983-05-18
JPH0414111B2 (enExample) 1992-03-11
AU9011382A (en) 1983-05-12
AU555244B2 (en) 1986-09-18
NO823647L (no) 1983-05-05
ES8402826A1 (es) 1984-03-01
CA1227487A (en) 1987-09-29
GB2112383A (en) 1983-07-20
ZA827973B (en) 1983-08-31
GR77053B (enExample) 1984-09-05
GB2112383B (en) 1985-07-17

Similar Documents

Publication Publication Date Title
ATE5965T1 (de) Imidazol-derivate, ihre herstellung und verwendung.
AU555244B2 (en) Substituted alkanoylimidazol-2-one derivatives
FI841154A0 (fi) Kromon- och tiokromonsubstituerade 1,4- dihydropyridinderivat, flera foerfaranden foer deras framstaellning och de deras anvaendning i laekemedel.
FI841153A0 (fi) Med kromon och tiokromon substituerade 1,4-dihydropyridonlaktoner, flera foerfaranden foer framstaellning av dessa och deras anvaendning i laekemedel.
ES2081858T3 (es) Compuestos de beta-fenoxinitrilo.
PL231277A1 (enExample)
DK43384A (da) Bicyclooctanderivater, fremgangsmaade til deres fremstilling og anvendelse heraf
IT1207057B (it) Policarbonati ramificati contenenti 2,4,6-tris(4'-idrossiaril)-ammino-s-triazine.
DK588484A (da) Thiolan-2,4-dion-3-carboxamider, deres fremstilling og anvendelse tilbekaempelse af skadelige organismer
DK513281A (da) Fremgangsaade til fremstilling af 3-thiovinylcephalosproner
FI852249L (fi) Foerfarande foer framstaellning av nya isoxazolokinolinoner.
ES2054636T3 (es) Derivados de acido 2,2-dimetil-ciclopropancarboxilico.
GR3007320T3 (enExample)
ES2011442A4 (es) Grametocidas
DK379381A (da) N-sulfenylerede urinstoffer fremgangsmaade til deres fremstilling og deres anvendelse som fungicider
ATE27601T1 (de) N-jodpropargyl-chlormethansulfonamide.
GB8324664D0 (en) N-substituted tetrahydrothiazines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee